🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or prison.

Service Response and Content Elimination

Based on TikTok, the service has taken down violative content and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, filled with images of slimming results, glowing reviews and detailed instructions for preparing or administering at home.

After minutes of joining one community, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.

Product Details and Costs

Within these groups, messages display dark colored packages with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to possibly serious health risks”.